48
Participants
Start Date
February 29, 2012
Primary Completion Date
March 31, 2012
Study Completion Date
May 31, 2012
HIP0901 capsule (Fenofibric acid) Fasting conditions/ Fed conditions
The study drug(HIP0901 capsule(Fenofibric acid, 135mg)) will be administrated under fed or fasting conditions
Korea University Anam Hospital, Seoul
Lead Sponsor
Hanmi Pharmaceutical Company Limited
INDUSTRY